Related Experiment Video
Updated: Jan 9, 2026

08:52
Profiling Sensitivity to Targeted Therapies in EGFR-Mutant NSCLC Patient-Derived Organoids
Published on: November 22, 2021
4.5K
Flawed FLAURA Comparisons and Nonrandom Biomarker Missingness in U.S. Osimertinib Cohort Study
1Second Ward of Bone and Soft Tissue Tumor Surgery, Cancer Hospital of Dalian University of Technology, Cancer Hospital of China Medical University, Liaoning Cancer Hospital & Institute, Shenyang, People's Republic of China; The Liaoning Provincial Key Laboratory of Interdisciplinary Research on Gastrointestinal Tumor Combining Medicine with Engineering, Shenyang, People's Republic of China; Institute of Cancer Medicine, Faculty of Medicine, Dalian University of Technology, Dalian, People's Republic of China.
Summary
No abstract available in PubMed .

